Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse

描述（由申请人提供）：我们建议在谷胱甘肽S-转移酶A3敲除小鼠（mGSTA3-/-或KO）中使用黄曲霉毒素肝癌发生的新实验模型来探索卵圆细胞（OCs）作为肝细胞癌（HCC）前体的作用，这在其他实验模型中是不可能的。HCC是世界范围内癌症死亡的主要原因，而饮食中的黄曲霉毒素B1 （AFB1）暴露是一个主要的危险因素。成年小鼠对AFB1诱导的肝损伤具有抗性，因为高水平的组成性表达mGSTA3可以解毒活化的AFB1。人类没有这种有效的解毒途径，因此mGSTA3-/-小鼠在AFB1代谢和敏感性方面可能被认为是人源化的。雄性和雌性mGSTA3 KO小鼠对低剂量AFB1均有肝损伤和大量OC增殖的反应。在Specific Aim 1中，我们将通过测量AFB1代谢的步骤、AFB1- dna加合物的水平和肝组织氧化损伤的程度来确定mGSTA3缺失对AFB1诱导的毒性的影响。这将提供AFB1致癌机制的见解，并应解释我们所观察到的雄性和雌性mGSTA3-/-小鼠对急性AFB1毒性的易感性差异。在Specific Aim 2中，mGSTA3-/-小鼠的四种AFB1暴露方案将被用来确定一种或几种最适合研究AFB1诱导的hcc损伤和发展的方案。这些模型将被设计为针对卵形细胞，模拟起始+促进方案，并包括与慢性肝炎易感性转基因小鼠的杂交。在Specific Aim 3中，将具体讨论卵圆细胞增殖后的命运。在AFB1诱导的肝损伤后，将在不同的AFB1暴露方案下研究它们的起源、扩增和分化为成熟细胞或肝癌。mGSTA3-/-小鼠的卵形细胞反应比其他小鼠模型更大，生长模式不同，与人类健康更相关。这些研究将为黄曲霉毒素b1相关的癌变提供新的见解，确定导致肿瘤发展的事件序列，确定卵圆细胞作为癌症干细胞的作用，并提供未来可以靶向预防afb1诱导的肝毒性和癌症的机制。

DESCRIPTION (provided by applicant): We propose to use a new experimental model of aflatoxin hepatocarcinogenesis in glutathione S- transferase A3 knockout mice (mGSTA3-/- or KO) to explore the role of oval cells (OCs) as precursors to hepatocellular carcinoma (HCC) not possible in other experimental models. HCC is a leading cause of cancer mortality worldwide, and dietary aflatoxin B1 (AFB1) exposure is a major risk factor. Adult mice are resistant to AFB1-induced liver injury because of high levels of constitutively expressed mGSTA3 that detoxifies activated AFB1. Humans do not have this efficient detoxification pathway, so that the mGSTA3-/- mice may be considered humanized in regard to AFB1 metabolism and sensitivity. Both male and female mGSTA3 KO mice respond to low doses of AFB1 with liver injury and massive OC proliferation. In Specific Aim 1, we will define the effects of loss of the mGSTA3 on AFB1-induced toxicity, by measuring the steps of AFB1 metabolism, the levels of AFB1-DNA adducts and extent of oxidative damage in liver tissues. This will provide a mechanistic insight into AFB1 carcinogenesis and should explain the differences in susceptibility to acute AFB1 toxicity between male and female mGSTA3-/- mice that we have observed. In Specific Aim 2, four regimens of AFB1 exposure in mGSTA3-/- mice will be used to determine one, or several, that would best serve to study the AFB1-induced injury and development of HCCs. The models will be designed to target oval cells, mimic initiation + promotion protocols and include cross-breeding with chronic hepatitis-prone transgenic mice. In Specific Aim 3, the fate of oval cells after proliferation will be specifically addressed. Following AFB1- induced liver injury, their origin, expansion and differentiation into either mature cells or to liver cancer, will be studied under different AFB1 exposure protocols. The oval cell response in mGSTA3-/- mice is much greater, different in growth pattern and more relevant to human health than other mouse models reported. These studies will provide new insights into aflatoxin B1-associated carcinogenesis, identify the sequence of events that leads to tumor development, determine the role of oval cells as cancer stem cells and provide mechanisms that can be targeted to prevent AFB1-induced liver toxicity and cancer in the future.